Skip to Main content Skip to Navigation
Journal articles

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

Cyrille Touzeau 1, 2 Steven Le Gouill 2, 1 Béatrice Mahé 2 Jean-Samuel Boudreault 2 Thomas Gastinne 2 Nicolas Blin 2 Hélène Caillon 3 Christelle Dousset 2, 1 Martine Amiot 2, 1 Philippe Moreau 2, 1, *
* Corresponding author
1 CRCNA - Centre de Recherche en Cancérologie Nantes-Angers
2 Unité d'Investigation Clinique - Service d'Hématologie Clinique [Nantes]
3 Laboratoire de Biochimie [Nantes]
Abstract : no abstract
Keywords : t(11 BH3 mimetics Venetoclax BCL-2 Multiple Myeloma 14)
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-01445538
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, January 25, 2017 - 9:29:34 AM
Last modification on : Wednesday, November 10, 2021 - 3:32:03 PM
Long-term archiving on: : Wednesday, April 26, 2017 - 1:10:12 PM

File

Vignette du document
CTvenetoclaxEq10.pdf
Files produced by the author(s)

Identifiers

Collections

INSERM | CNRS | UNAM | CRCNA

Citation

Cyrille Touzeau, Steven Le Gouill, Béatrice Mahé, Jean-Samuel Boudreault, Thomas Gastinne, et al.. Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14). Haematologica, Ferrata Storti Foundation, 2017, [Epub ahead of print]. ⟨10.3324/haematol.2016.160408⟩. ⟨inserm-01445538⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles